LANXESS Inkomsten in het verleden
Verleden criteriumcontroles 0/6
De winst van LANXESS is gedaald met een gemiddeld jaarlijks percentage van -48%, terwijl de winst van de Chemicals -industrie jaarlijks daalde met 3.5%. De inkomsten zijn daalde met een gemiddeld percentage van 3.6% per jaar.
Belangrijke informatie
-47.99%
Groei van de winst
-47.99%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.41% |
| Inkomstengroei | -3.57% |
| Rendement op eigen vermogen | -19.14% |
| Nettomarge | -12.06% |
| Volgende winstupdate | 05 Nov 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • Jul 17
LXS: Future Rally Looks Vulnerable As Middle East Conflict Risks Deepen
LANXESS sees its analyst derived fair value estimate move from €11.00 to €12.50, as analysts factor in modestly adjusted growth assumptions, sharply lower profit margin expectations, and a much higher future P/E multiple reflected in recent price target changes between €13 and €18. Analyst Commentary Recent commentary on LANXESS has tilted clearly cautious, with several bearish analysts revisiting both ratings and price targets.Analyse-artikel • Jun 20
LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts
LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...
Narratiefupdate • Jun 17
LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk
The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.Narratiefupdate • Jun 02
LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens
LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.Analyse-artikel • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...Narratiefupdate • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Narratiefupdate • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Narratiefupdate • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.Narratiefupdate • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Narratiefupdate • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Narratiefupdate • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Narratiefupdate • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Narratiefupdate • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Narratiefupdate • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Analyse-artikel • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Narratiefupdate • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Analyse-artikel • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narratiefupdate • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Narratiefupdate • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Narratiefupdate • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Narratiefupdate • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Narratiefupdate • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Narratiefupdate • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Analyse-artikel • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Nieuw narratief • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Analyse-artikel • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Analyse-artikel • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analyse-artikel • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analyse-artikel • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analyse-artikel • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Analyse-artikel • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Analyse-artikel • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Analyse-artikel • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyse-artikel • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analyse-artikel • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Opbrengsten en kosten
Opbrengsten en kosten
Hoe LANXESS geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 26 | 5,545 | -669 | 1,060 | 93 |
| 31 Mar 26 | 5,450 | -661 | 1,065 | 93 |
| 31 Dec 25 | 5,673 | -577 | 1,091 | 96 |
| 30 Sep 25 | 5,888 | -243 | 1,118 | 97 |
| 30 Jun 25 | 6,148 | -165 | 1,164 | 102 |
| 31 Mar 25 | 6,360 | -136 | 1,176 | 105 |
| 31 Dec 24 | 6,366 | -177 | 1,177 | 104 |
| 30 Sep 24 | 6,319 | -690 | 1,167 | 105 |
| 30 Jun 24 | 6,322 | -822 | 1,164 | 102 |
| 31 Mar 24 | 6,422 | -951 | 1,182 | 100 |
| 31 Dec 23 | 6,714 | -843 | 1,238 | 99 |
| 30 Sep 23 | 7,251 | -280 | 1,350 | 102 |
| 30 Jun 23 | 7,835 | -65 | 1,438 | 104 |
| 31 Mar 23 | 8,056 | 128 | 1,439 | 105 |
| 31 Dec 22 | 8,088 | 184 | 1,398 | 102 |
| 30 Sep 22 | 7,794 | 191 | 1,330 | 100 |
| 30 Jun 22 | 7,190 | 147 | 1,229 | 99 |
| 31 Mar 22 | 6,660 | 146 | 1,171 | 96 |
| 31 Dec 21 | 6,101 | 116 | 1,107 | 95 |
| 30 Sep 21 | 5,925 | 119 | 1,050 | 99 |
| 30 Jun 21 | 5,805 | 105 | 1,018 | 100 |
| 31 Mar 21 | 5,772 | 863 | 1,022 | 105 |
| 31 Dec 20 | 6,104 | 892 | 1,056 | 108 |
| 30 Sep 20 | 6,237 | 883 | 1,088 | 110 |
| 30 Jun 20 | 6,480 | 938 | 1,110 | 113 |
| 31 Mar 20 | 6,768 | 231 | 1,127 | 113 |
| 31 Dec 19 | 6,802 | 255 | 1,115 | 114 |
| 30 Sep 19 | 6,559 | 266 | 1,055 | 105 |
| 30 Jun 19 | 6,641 | 243 | 1,066 | 106 |
| 31 Mar 19 | 6,746 | 212 | 1,072 | 106 |
| 31 Dec 18 | 6,824 | 190 | 1,084 | 109 |
| 30 Sep 18 | 7,066 | 144 | 1,166 | 110 |
| 30 Jun 18 | 6,990 | 138 | 1,167 | 109 |
| 31 Mar 18 | 6,873 | 63 | 1,165 | 110 |
| 31 Dec 17 | 6,530 | 23 | 1,111 | 103 |
| 30 Sep 17 | 6,810 | 73 | 1,103 | 116 |
| 30 Jun 17 | 7,021 | 83 | 1,087 | 121 |
| 31 Mar 17 | 7,252 | 166 | 1,072 | 124 |
| 31 Dec 16 | 7,699 | 192 | 1,116 | 131 |
| 30 Sep 16 | 7,590 | 205 | 1,092 | 128 |
| 30 Jun 16 | 7,622 | 184 | 1,093 | 126 |
| 31 Mar 16 | 7,784 | 196 | 1,097 | 128 |
| 31 Dec 15 | 7,902 | 165 | 1,078 | 130 |
| 30 Sep 15 | 8,000 | 82 | 1,060 | 134 |
Kwaliteitswinsten: LXS is momenteel verliesgevend.
Groeiende winstmarge: LXS is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: LXS is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 48% per jaar.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van LXS over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: LXS is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Chemicals industrie ( -13.3% ).
Rendement op eigen vermogen
Hoge ROE: LXS heeft een negatief Return on Equity ( -19.14% ), omdat het momenteel verliesgevend is.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/17 07:22 |
| Aandelenkoers aan het einde van de dag | 2026/09/17 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
LANXESS Aktiengesellschaft wordt gevolgd door 33 analisten. 13 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Anil Shenoy | Barclays |
| James Knight | Barclays |
| Andres Castanos-Mollor | Berenberg |